CoChat
Sign Up
Cited by 10

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure

Scalabrino, Giuseppe·2022·Biomedicines
DOI 10.3390/biomedicines10040815PMC PMC9026986
Open this paper in CoChat — free account

Abstract

The pathogenesis of multiple sclerosis (MS) remains enigmatic and controversial. Myelin sheaths in the central nervous system (CNS) insulate axons and allow saltatory nerve conduction. MS brings about the destruction of myelin sheaths and the myelin-producing oligodendrocytes (ODCs). The conundrum of remyelination failure is, therefore, crucial in MS. In this review, the roles of epidermal growth factor (EGF), normal prions, and cobalamin in CNS myelinogenesis are briefly summarized. Thereafter, some findings of other authors and ourselves on MS and MS-like models are recapitulated, because they have shown that: (a) EGF is significantly decreased in the CNS of living or deceased MS patients; (b) its repeated administration to mice in various MS-models prevents demyelination and inflammatory reaction; (c) as was the case for EGF, normal prion levels are decreased in the MS CNS, with a strong correspondence between liquid and tissue levels; and (d) MS cobalamin levels are increased in the cerebrospinal fluid, but decreased in the spinal cord. In fact, no remyelination can occur in MS if these molecules (essential for any form of CNS myelination) are lacking. Lastly, other non-immunological MS abnormalities are reviewed. Together, these results have led to a critical reassessment of MS pathogenesis, partly because EGF has little or no role in immunology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines10040815

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The main effects of epidermal growth factor (EGF) on oligodendrocytes (ODCs) and astrocytes (ASTs). The green arrows indicate stimulation. See text for details and references. IGF = insulin-like growth factor; NSC = neural stem cell; OPC = oligodendrocyte precursor cell; PrPC = normal cellular prion protein.
Figure 1 The main effects of epidermal growth factor (EGF) on oligodendrocytes (ODCs) and astrocytes (ASTs). The green arrows indicate stimulation. See text for details and references. IGF = insulin-like growth factor; NSC = neural stem cell; OPC = oligodendrocyte precursor cell; PrPC = normal cellular prion protein.CC BY · PubMed Central
Figure 2 Various physiological molecules of the central nervous system (CNS) act through the Akt signaling pathway. The pivotal role of the Akt signaling pathway in CNS myelination is evident. See text for details and references. Cbl = cobalamin; ECM = extracellular matrix; EGF = epidermal growth factor; IGF = insulin-like growth factor; mTORC = mammalian target of rapamycin complex; NRG = neuregulin; ODC = oligodendrocyte; PrPC = normal cellular prion protein.
Figure 2 Various physiological molecules of the central nervous system (CNS) act through the Akt signaling pathway. The pivotal role of the Akt signaling pathway in CNS myelination is evident. See text for details and references. Cbl = cobalamin; ECM = extracellular matrix; EGF = epidermal growth factor; IGF = insulin-like growth factor; mTORC = mammalian target of rapamycin complex; NRG = neuregulin; ODC = oligodendrocyte; PrPC = normal cellular prion protein.CC BY · PubMed Central
Figure 3 Schematic diagram of the epidermal growth factor (EGF) levels in multiple sclerosis (MS) central nervous system (CNS), EGF expression, and the effects of its in vivo or in vitro administration in different models of experimental allergic encephalomyelitis (EAE) and chemically or virally-induces CNS demyelination. See the text for details and references. CSF = cerebrospinal fluid; MPG = myelin oligodendrocyte-specific glycoprotein.
Figure 3 Schematic diagram of the epidermal growth factor (EGF) levels in multiple sclerosis (MS) central nervous system (CNS), EGF expression, and the effects of its in vivo or in vitro administration in different models of experimental allergic encephalomyelitis (EAE) and chemically or virally-induces CNS demyelination. See the text for details and references. CSF = cerebrospinal fluid; MPG = myelin oligodendrocyte-specific glycoprotein.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 460

  1. Love, 2015, Demyelinating Diseases, Greenfield’s Neuropathology, Volume 2, 1297
  2. Wingerchuk, 2001, Multiple sclerosis: Current pathophysiological concepts, Lab. Investig., 81, 263, 10.1038/labinvest.3780235 · DOI
  3. Peterson, 2005, Neuropathobiology of multiple sclerosis, Neurol. Clin., 23, 107, 10.1016/j.ncl.2004.09.008 · DOI
  4. Wood, P.L. (2003). Neuroimmunologic Mechanisms in the Etiology of Multiple Sclerosis. Neuroinflammation. Mechanisms and Management, Humana Press. [2nd ed.].
  5. Lucchinetti, 2005, The pathology of multiple sclerosis, Neurol. Clin., 23, 77, 10.1016/j.ncl.2004.09.002 · DOI
  6. Levin, 2014, Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms, Degen. Neurol. Neuromus. Dis., 4, 49
  7. Waxman, 2006, Ions, energy and axonal injury: Towards a molecular neurology of multiple sclerosis, Trends Mol. Med., 12, 192, 10.1016/j.molmed.2006.03.001 · DOI
  8. Stadelmann, 2005, The spectrum of multiple sclerosis: New lesson from pathology, Curr. Opin. Neurol., 18, 221, 10.1097/01.wco.0000169736.60922.20 · DOI
  9. Duncan, I.D., and Franklin, R.J.M. (2013). Demyelination and Remyelination in Multiple Sclerosis. Myelin Repair and Neuroprotection in Multiple Sclerosis, Springer. [1st ed.]. · DOI
  10. Groppa, S., and Meuth, S.G. (2021). Pathophysiological Basis of Autoimmune-Initiated/Mediated Neurodegeneration. Translational Methods for Multiple Sclerosis Research, Humana Press.
  11. Pérez-Pérez, S., Dominguez-Mozo, M.I., Garcia-Martínez, M.Á., Ballester-González, R., Gañán, I., Arroyo, R., and Alvarez-Lafuente, R. (2022). Epstein-Barr virus load correlates with multiple sclerosis-associated retrovirus envelope expression. Biomedicines, 10. · DOI
  12. Pimentel, 1994, Epidermal Growth Factor, Handbook of Growth Factors, Volume 2, 97
  13. Baserga, R. (1981). Epidermal Growth Factor. Tissue Growth Factors, Springer. · DOI
  14. Iwakura, 2013, Erb1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: Pathological implications in schizophrenia and Parkinson’s disease, Front. Cell. Neurosci., 7, 4, 10.3389/fncel.2013.00004 · DOI
  15. Hirata, 1982, Presence of human epidermal growth factor in human cerebrospinal fluid, J. Clin. Endocrinol. Metab., 55, 1174, 10.1210/jcem-55-6-1174 · DOI
  16. Fallon, 1984, Epidermal growth factor immunoreactive material in the central nervous system: Location and development, Science, 224, 1107, 10.1126/science.6144184 · DOI
  17. Lazar, 1992, Regional distribution and developmental expression of epidermal growth factor and transforming growth factor-α mRNA in mouse brain by a quantitative nuclease protection assay, J. Neurosci., 12, 1688, 10.1523/JNEUROSCI.12-05-01688.1992 · DOI
  18. Piao, 2005, Differential distribution of peptides in the epidermal growth factor family and phosphorylation of ErbB1 receptor in adult rat brain, Neurosci. Lett., 390, 21, 10.1016/j.neulet.2005.07.048 · DOI
  19. Zeng, 2014, Epidermal growth factor, from gene organization to bedside, Sem. Cell. Dev. Biol., 28, 2, 10.1016/j.semcdb.2014.01.011 · DOI
  20. Chevalier, 2011, Enteric glia promote intestinal mucosal healing via activation of focal adhesion kinase and release of proEGF, Am. J. Physiol. Gastrointest. Liver Physiol., 300, G976, 10.1152/ajpgi.00427.2010 · DOI
  21. Neunlist, 2013, The digestive neuronal-glial-epithelial unit: A new actor in gut health and disease, Nat. Rev. Gastroenterol. Hepatol., 10, 90, 10.1038/nrgastro.2012.221 · DOI
  22. Scalabrino, 1995, Subacute combined degeneration in the spinal cords of totally gastrectomized rats. Ornithine decarboxylase induction, cobalamin status, and astroglial reaction, Lab. Investig., 72, 114
  23. Sharma, H.S., and Westman, J. (2004). Transport of Cytokines and Neurotrophins across the Blood-Brain Barrier and Their Regulation after Spinal Cord Injury. Blood-Spinal Cord and Brain Barriers in Health and Disease, Elsevier-Academic Press.
  24. Pan, 1999, Entry of EGF into brain is rapid and saturable, Peptides, 20, 1091, 10.1016/S0196-9781(99)00094-7 · DOI
  25. Nagano, 2007, In vivo administration of epidermal growth factor and its homologue attenuates developmental maturation of functional excitatory synapses in cortical GABAergic neurons, Eur. J. Neurosci., 25, 380, 10.1111/j.1460-9568.2007.05297.x · DOI
  26. Sharma, H.S., and Westman, J. (2004). Volume Transmission-Mediated Protective Impact of Choroid Plexus-Cerebrospinal Fluid Growth Factors on Forebrain Ischemic Injury. Blood-Spinal Cord and Brain Barriers in Health and Disease, Elsevier-Academic Press.
  27. Scalabrino, 2009, The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: Lessons learned from its deficiency, Prog. Neurobiol., 88, 203, 10.1016/j.pneurobio.2009.04.004 · DOI
  28. Fenech, 2012, Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity, Mut. Res., 733, 21, 10.1016/j.mrfmmm.2011.11.003 · DOI
  29. Scalabrino, 2009, Vitamin-regulated cytokines and growth factors in the central nervous system and elsewhere, J. Neurochem., 111, 1309, 10.1111/j.1471-4159.2009.06417.x · DOI
  30. Wolffenbuttel, 2019, The many faces of cobalamin (Vitamin B12) deficiency, Mayo Clin. Proc. Inn. Qual. Out., 3, 200, 10.1016/j.mayocpiqo.2019.03.002 · DOI
  31. Rai, S.N., Singh, P., Steinbusch, H.W.M., Vamanu, E., Ashraf, G., and Singh, M.P. (2021). The role of vitamins in neurodegenerative disease: An update. Biomedicines, 9. · DOI
  32. Linden, 2008, Physiology of the prion protein, Physiol. Rev., 88, 673, 10.1152/physrev.00007.2007 · DOI · Paper page
  33. Castle, 2017, Physiological functions of the cellular prion protein, Front. Mol. Biosci., 4, 19, 10.3389/fmolb.2017.00019 · DOI
  34. Linden, 2017, The biological function of the prion protein: A cell surface scaffold of signalling modules, Front. Mol. Neurosci., 10, 77, 10.3389/fnmol.2017.00077 · DOI
  35. Harris, 1999, Cellular biology of prion diseases, Clin. Microbiol. Rev., 12, 429, 10.1128/CMR.12.3.429 · DOI
  36. Mehrpour, 2010, Prion protein: From physiology to cancer biology, Cancer Lett., 290, 1, 10.1016/j.canlet.2009.07.009 · DOI
  37. Westergard, 2007, The cellular prio protein (PrPc): Its physiological function and role in disease, Biochim. Biophys. Acta, 1172, 629, 10.1016/j.bbadis.2007.02.011 · DOI
  38. Rutishauser, D., Mertz, K.D., Moos, R., Brunner, E., Rülicke, T., Calella, A.M., and Aguzzi, A. (2009). The comprehensive native interactome of a fully functional tagged prion protein. PLoS ONE, 4. · DOI
  39. Chiesa, R. (2015). The elusive role of the prion protein and the mechanism of toxicity in prion disease. PLoS Pathog., 11. · DOI
  40. Scalabrino, 2013, Cobalamin and normal prions: A new horizon for cobalamin neurotrophism, Biochemie, 95, 1041, 10.1016/j.biochi.2013.01.002 · DOI
  41. Baumann, 2007, Lethal recessive myelin toxicity of prion protein lacking its central domain, EMBO J., 26, 538, 10.1038/sj.emboj.7601510 · DOI
  42. Mitteregger, 2007, The role of octapeptide region in neuroprotective function of the cellular prion protein, Brain Pathol., 17, 174, 10.1111/j.1750-3639.2007.00061.x · DOI
  43. Li, 2007, Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice, EMBO J., 26, 2777, 10.1038/sj.emboj.7601726 · DOI
  44. Scalabrino, 2014, Myelin damage due to local quantitative abnormalities in normal prion levels: Evidence from subacute combined degeneration and multiple sclerosis, J. Neurol., 261, 1451, 10.1007/s00415-013-7152-3 · DOI
  45. Veber, 2015, Are PrPcs involved in some human myelin diseases? Relating experimental studies to human pathology, J. Neurol. Sci., 359, 396, 10.1016/j.jns.2015.09.365 · DOI
  46. Watts, 2018, The function of the cellular prion protein in health and disease, Acta Neuropathol., 135, 159, 10.1007/s00401-017-1790-y · DOI
  47. Scalabrino, 2014, Relationship between cobalamin, epidermal growth factor, and normal prions in the myelin maintenance of central nervous system, Int. J. Biochem. Cell Biol., 55, 232, 10.1016/j.biocel.2014.09.011 · DOI
  48. Scalabrino, 2020, Epidermal growth factor in the CNS: A beguiling journey from integrated cell biology to multiple sclerosis, An extensive translational overview, Cell. Mol. Neurobiol., 42, 891, 10.1007/s10571-020-00989-x · DOI
  49. Stadelmann, 2019, Myelin in the central nervous system: Structure, function, and pathology, Physiol. Rev., 99, 1381, 10.1152/physrev.00031.2018 · DOI
  50. Lazzarini, 2004, Structure of the Myelinated Axon, Myelin Biology and Disorders, Volume 1, 3
  51. Aggarwal, 2011, Central nervous system myelin: Structure, synthesis, and assembly, Trends Cell Biol., 21, 585, 10.1016/j.tcb.2011.06.004 · DOI · Paper page
  52. Lazzarini, 2004, Cell Biology of Myelin Assembly, Myelin Biology and Disorders, Volume 1, 29
  53. Sherman, 2005, Mechanisms of axon ensheathment and myelin growth, Nat. Rev. Neurosci., 6, 683, 10.1038/nrn1743 · DOI · Paper page
  54. Lazzarini, 2004, The Transport, Assembly, and Function of Myelin Lipids, Myelin Biology and Disorders, Volume 1, 57
  55. Hughes, 2016, The cell biology of CNS myelination, Curr. Opin. Neurobiol., 39, 93, 10.1016/j.conb.2016.04.013 · DOI
  56. Simons, 2016, Oligodendrocytes: Myelination and Axonal Support, Cold Sping Harbor Persp. Biol., 8, a020479, 10.1101/cshperspect.a020479 · DOI
  57. Miron, 2011, Cells of the oligodendroglial lineage, myelination, and remyelination, Biochim. Biophys. Acta, 1812, 184, 10.1016/j.bbadis.2010.09.010 · DOI
  58. Tognatta, 2020, Astrocytes are required for oligodendrocyte survival and maintenance of myelin compaction and integrity, Front. Cell. Neurosci., 14, 74, 10.3389/fncel.2020.00074 · DOI
  59. Nutma, E., van Gent, D., Amor, S., and Peferoen, L.A.N. (2020). Astrocyte and oligodendrocyte cross-talk in the central nervous system. Cells, 9. · DOI
  60. Barnett, 2012, Myelination: Do astrocytes play a role?, Neuroscientist, 20, 1
  61. Miron, 2019, Astrocytes in myelination and remyelination, Neurosci. Lett., 713, 134532, 10.1016/j.neulet.2019.134532 · DOI
  62. Gibson, 2014, Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain, Science, 344, 1252304, 10.1126/science.1252304 · DOI · Paper page
  63. Saab, 2013, The role of myelin and oligodendrocytes in axonal energy metabolism, Curr. Opin. Neurobiol., 23, 1065, 10.1016/j.conb.2013.09.008 · DOI · Paper page
  64. Lee, 2012, Oligodendroglia metabolically support axons and contribute to neurodegeneration, Nature, 487, 443, 10.1038/nature11314 · DOI · Paper page
  65. Lazzarini, 2004, Functional Organization of the Nodes of Ranvier, Myelin Biology and Disorders, Volume 1, 89
  66. Nave, 2010, Myelination and the trophic support of long axons, Nat. Rev. Neurosci., 11, 275, 10.1038/nrn2797 · DOI · Paper page
  67. Lazzarini, 2004, Electrophysiological Consequences of Myelination, Myelin Biology and Disorders, Volume 1, 117
  68. Simons, 2006, Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis, J. Cell Sci., 119, 4381, 10.1242/jcs.03242 · DOI
  69. Bercury, 2015, Dynamics and mechanism of CNS myelination, Dev. Cell., 32, 447, 10.1016/j.devcel.2015.01.016 · DOI · Paper page
  70. Tomassy, 2016, Diversity matters: A revised guide to myelination, Trends Cell Biol., 26, 135, 10.1016/j.tcb.2015.09.002 · DOI · Paper page
  71. Chang, 2016, Remodeling myelination: Implications for mechanisms of neural plasticity, Nat. Neurosci., 19, 190, 10.1038/nn.4200 · DOI
  72. Alizadeh, 2015, Myelin damage and repair on pathologic CNS: Challenges and prospects, Front. Mol. Neurosci., 8, 35, 10.3389/fnmol.2015.00035 · DOI
  73. Nave, 2014, Myelination of the nervous system: Mechanisms and functions, Annu. Rev. Cell Dev. Biol., 30, 503, 10.1146/annurev-cellbio-100913-013101 · DOI · Paper page
  74. Cayre, 2021, Myelin repair: From animal model to humans, Front. Cell. Neurosci., 15, 604865, 10.3389/fncel.2021.604865 · DOI
  75. Chamberlain, 2016, Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis, Neuropharmacology, 110, 633, 10.1016/j.neuropharm.2015.10.010 · DOI
  76. Piaton, 2010, Axon-oligodendrocyte interactions during developmental myelination, demyelination and repair, J. Neurochem., 114, 1243, 10.1111/j.1471-4159.2010.06831.x · DOI
  77. Trapp, 2008, Multiple sclerosis: An immune or neurodegenerative disorder?, Annu. Rev. Neurosci., 31, 247, 10.1146/annurev.neuro.30.051606.094313 · DOI · Paper page
  78. Kornek, 2000, Multiple sclerosis and chronic autoimmune encephalomyelitis. A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions, Am. J. Pathol., 157, 267, 10.1016/S0002-9440(10)64537-3 · DOI
  79. Irvine, 2008, Remyelination protects axons from demyelination-associated axon degeneration, Brain, 131, 1464, 10.1093/brain/awn080 · DOI · Paper page
  80. Duncan, I.D., and Franklin, R.J.M. (2013). Endogenous Remyelination in the CNS. Myelin Repair and Neuroprotection in Multiple Sclerosis, Springer. · DOI
  81. Campbell, 2012, Mitochondrial changes within axons in multiple sclerosis: An update, Curr. Opin. Neurol., 25, 221, 10.1097/WCO.0b013e3283533a25 · DOI
  82. Hinks, 1999, Distinctive patterns of PDGF-A, FGF-2, IGF-1 and TGF-β1 gene expression during remyelination of experimentally-induced spinal cord demyelination, Mol. Cell. Neurosci., 14, 153, 10.1006/mcne.1999.0771 · DOI
  83. Fancy, 2011, Myelin regeneration: A recapitulation of development?, Annu. Rev. Neurosci., 34, 21, 10.1146/annurev-neuro-061010-113629 · DOI
  84. Hanafy, 2011, Regulation of remyelination in multiple sclerosis, FEBS Lett., 585, 3821, 10.1016/j.febslet.2011.03.048 · DOI
  85. Werkman, 2021, Macroglial diversity: White and grey areas and relevance to remyelination, Cell. Mol. Life Sci., 78, 143, 10.1007/s00018-020-03586-9 · DOI
  86. Clemente, 2013, The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases, Front. Cell. Neurosci., 7, 268, 10.3389/fncel.2013.00268 · DOI
  87. Kovacs, G.G., and Alafuzoff, I. (2018). Inflammatory demyelinating diseases of the central nervous system. Handbook of Clinical Neurology, Neuropathology, Elsevier.
  88. Frohman, 2006, Multiple sclerosis—The plaque and its pathogenesis, N. Engl. J. Med., 354, 942, 10.1056/NEJMra052130 · DOI
  89. Frischer, 2015, Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque, Ann. Neurol., 78, 710, 10.1002/ana.24497 · DOI · Paper page
  90. Lucchinetti, 2000, Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination, Ann. Neurol., 47, 707, 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q · DOI
  91. Petropoulos, 1983, Alpha-Fetoprotein and albumin mRNA levels in liver regeneration and carcinogenesis, J. Biol. Chem., 258, 4901, 10.1016/S0021-9258(18)32512-2 · DOI
  92. Gao, 2021, All routes lead to Rome: Multifaceted origin of hepatocytes during liver regeneration, Cell Regen., 10, 2, 10.1186/s13619-020-00063-3 · DOI
  93. Ritter, 2003, The molecular basis of myocardial hypertrophy and heart failure, Trends Mol. Med., 9, 313, 10.1016/S1471-4914(03)00114-X · DOI
  94. Lyon, 2015, Mechanotransduction in cardiac hypertrophy and failure, Circ. Res., 116, 1462, 10.1161/CIRCRESAHA.116.304937 · DOI
  95. Kuhlmann, 2003, Remyelination in multiple sclerosis, J. Neurol. Sci., 206, 181, 10.1016/S0022-510X(02)00191-0 · DOI
  96. Macchi, 2014, Oligodendrogenesis in the normal and pathological central nervous system, Front. Neurosci., 8, 145
  97. Domingues, 2016, Oligodendrocyte, astrocyte, and microglia crosstalk in myelin development, damage, and repair, Front. Cell Dev. Biol., 4, 71
  98. Patel, 2011, Mediators of oligodendrocyte differentiation during remyelination, FEBS Lett., 585, 3730, 10.1016/j.febslet.2011.04.037 · DOI
  99. Parras, 2020, Chromatin remodelers in oligodendroglia, Glia, 68, 1604, 10.1002/glia.23837 · DOI
  100. Tiane, A., Schepers, M., Rombaut, B., Hupperts, R., Prickaerts, J., Hellings, N., van den Hove, D., and Vanmierlo, T. (2019). From OPC to oligodendrocyte: An epigenetic journey. Cells, 8. · DOI
  101. Elbaz, 2019, Molecular control of oligodendrocyte development, Trends Neurosci., 42, 263, 10.1016/j.tins.2019.01.002 · DOI
  102. Verhaagen, 2009, Remyelination in multiple sclerosis, Progress in Brain Research, Volume 175, 453, 10.1016/S0079-6123(09)17530-1 · DOI
  103. Wegner, 2008, A matter of identity: Transcriptional control in oligodendrocytes, J. Mol. Neurosci., 35, 3, 10.1007/s12031-007-9008-8 · DOI
  104. Copray, 2009, Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging, Glia, 57, 1579, 10.1002/glia.20881 · DOI
  105. Liu, 2010, Epigenetic regulation of oligodendrocyte identity, Trends Neurosci., 33, 193, 10.1016/j.tins.2010.01.007 · DOI
  106. Liu, 2016, Epigenetic control of oligodendrocyte development: Adding new players to old keepers, Curr. Opin. Neurobiol., 39, 133, 10.1016/j.conb.2016.06.002 · DOI
  107. Patrikios, 2006, Remyelination is extensive in a subset of multiple sclerosis patients, Brain, 129, 3165, 10.1093/brain/awl217 · DOI · Paper page
  108. Patani, 2007, Remyelination can be extensive in multiple sclerosis despite a long disease course, Neuropathol. Appl. Neurobiol., 33, 277, 10.1111/j.1365-2990.2007.00805.x · DOI
  109. Bramow, 2010, Demyelination versus remyelination in progressive multiple sclerosis, Brain, 133, 2983, 10.1093/brain/awq250 · DOI
  110. Reynolds, 1992, Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, Science, 255, 1707, 10.1126/science.1553558 · DOI · Paper page
  111. Black, 1990, Neuroblast mitosis in dissociated culture: Regulation and relationship to differentiation, J. Cell Biol., 110, 2073, 10.1083/jcb.110.6.2073 · DOI
  112. Armstrong, 1992, Pre-oligodendrocytes from adult human CNS, J. Neurosci., 12, 1538, 10.1523/JNEUROSCI.12-04-01538.1992 · DOI
  113. Los, 1993, Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia, Proc. Natl. Acad. Sci. USA, 90, 2074, 10.1073/pnas.90.5.2074 · DOI
  114. Zhang, 1999, Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity, Proc. Natl. Acad. Sci. USA, 96, 4089, 10.1073/pnas.96.7.4089 · DOI
  115. Decker, 1999, Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination, Eur. J. Neurosci., 11, 4357, 10.1046/j.1460-9568.1999.00873.x · DOI · Paper page
  116. Horner, 2000, Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord, J. Neurosci., 20, 2218, 10.1523/JNEUROSCI.20-06-02218.2000 · DOI · Paper page
  117. Chang, 2000, NG-2 positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions, J. Neurosci., 20, 6404, 10.1523/JNEUROSCI.20-17-06404.2000 · DOI
  118. Doetsch, 2003, A niche for adult neural stem cells, Curr. Opin. Genet. Dev., 13, 543, 10.1016/j.gde.2003.08.012 · DOI
  119. Xing, 2014, Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination, J. Neurosci., 34, 14128, 10.1523/JNEUROSCI.3491-13.2014 · DOI · Paper page
  120. Fancy, 2004, Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS, Mol. Cell. Neurosci., 27, 247, 10.1016/j.mcn.2004.06.015 · DOI
  121. Zawadzka, 2010, CNS-Resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination, Cell Stem Cell., 6, 578, 10.1016/j.stem.2010.04.002 · DOI · Paper page
  122. Marmur, 1998, Differentiation of oligodendroglial progenitors derived from cortical multipotent cells requires extrinsic signals including activation of gp130/LIFβ receptors, J. Neurosci., 18, 9800, 10.1523/JNEUROSCI.18-23-09800.1998 · DOI
  123. Gago, 2003, Control of cell survival and proliferation of postnatal PSA-NCAM+ progenitors, Mol. Cell. Neurosci., 22, 162, 10.1016/S1044-7431(02)00030-1 · DOI
  124. Nunes, 2003, Identification and isolation of multipotent neural progenitor cells from the subcortical white matter of the adult human brain, Nat. Med., 9, 439, 10.1038/nm837 · DOI
  125. Reynolds, 1996, Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell, Dev. Biol., 175, 1, 10.1006/dbio.1996.0090 · DOI
  126. 2013, The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain, Front. Cell. Neurosci., 7, 258
  127. Doetsch, 1999, Subventricular zone astrocytes are neural stem cells in the adult mammalian brain, Cell, 97, 703, 10.1016/S0092-8674(00)80783-7 · DOI · Paper page
  128. Laywell, 2000, Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain, Proc. Natl. Acad. Sci. USA, 97, 13883, 10.1073/pnas.250471697 · DOI
  129. Akkermann, 2017, Heterogenous populations of neural stem cells contribute to myelin repair, Neural Regen. Res., 12, 509, 10.4103/1673-5374.204999 · DOI
  130. Foerster, 2019, Diversity in the oligodendrocyte lineage: Plasticity or heterogeneity?, Glia, 67, 1797, 10.1002/glia.23607 · DOI
  131. 2017, White matter plasticity in the adult brain, Neuron, 96, 1239, 10.1016/j.neuron.2017.11.026 · DOI
  132. Covarrubias, 1995, Epidermal growth factor (EGF), transforming growth factor-α (TGF-α), and basic fibroblast growth factor (bFGF) differentially influence neural precursor cells of mouse embryonic mesencephalon, J. Neurosci. Res., 42, 172, 10.1002/jnr.490420204 · DOI
  133. Craig, 1996, In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adulte mouse brain, J. Neurosci., 16, 2649, 10.1523/JNEUROSCI.16-08-02649.1996 · DOI
  134. Martens, 2000, Separate proliferation kinetics of fibroblast growth factor-responsive and epidermal growth factor-responsive neural stem cells within the embryonic forebrain germinal zone, J. Neurosci., 20, 1085, 10.1523/JNEUROSCI.20-03-01085.2000 · DOI
  135. Kerninon, 2007, Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitors, Proc. Natl. Acad. Sci. USA, 104, 4694, 10.1073/pnas.0606835104 · DOI
  136. Brousse, 2015, Region and dynamic specificities of adult neural stem cells and oligodendrocyte precursors in myelin regeneration in the mouse brain, Biol. Open, 4, 980, 10.1242/bio.012773 · DOI · Paper page
  137. Tripathi, 2010, NG2 Glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease, J. Neurosci., 30, 16383, 10.1523/JNEUROSCI.3411-10.2010 · DOI · Paper page
  138. Lazzarini, 2004, Remyelination by Endogenous Glia, Myelin Biology and Disorders, Volume 1, 173
  139. Cantarella, 2008, Intranasal HB-EGF administration favors adult SVZ cell mobilization to demyelinated lesions in mouse corpus callosum, Devel. Neurobiol., 68, 223, 10.1002/dneu.20588 · DOI
  140. Decker, 2002, Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice, Proc. Natl. Acad. Sci. USA, 99, 13211, 10.1073/pnas.192314199 · DOI
  141. Cayre, 2006, Migrating and myelinating potential of subventricular zone neural progenitor cells in white matter tracts of the adult rodent brain, Mol. Cell. Neurosci., 31, 748, 10.1016/j.mcn.2006.01.004 · DOI
  142. Mecha, 2013, Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler’s virus model of multiple sclerosis: Implications for remyelination at lesions sites, Exp. Neurol., 250, 348, 10.1016/j.expneurol.2013.10.011 · DOI
  143. 2010, Dose-dependent of EGF on migration and differentiation of adult subventricular zone astrocytes, Glia, 58, 975, 10.1002/glia.20979 · DOI
  144. 2011, Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor, Brain Res. Rev., 67, 147, 10.1016/j.brainresrev.2011.01.001 · DOI
  145. Solanky, 2001, Proliferating oligodendrocytes are present in both active and chronic inactive multiple sclerosis plaques, J. Neurosci. Res., 65, 308, 10.1002/jnr.1155 · DOI
  146. Colognato, 2011, Glia unglued: How signals from the extracellular matrix regulate the development of myelinating glia, Dev. Neurobiol., 71, 924, 10.1002/dneu.20966 · DOI
  147. Mitew, 2014, Mechanisms regulating the development of oligodendrocytes and central nervous system, Neuroscience, 276, 29, 10.1016/j.neuroscience.2013.11.029 · DOI
  148. Boggs, 2006, Myelin basic protein: A multifunctional protein, Cell. Mol. Life Sci., 63, 1945, 10.1007/s00018-006-6094-7 · DOI · Paper page
  149. Emery, 2015, Transcriptional and epigenetic regulation of oligodendrocyte development and myelination in the central nervous system, Cold Spring Harb. Perspect. Biol., 7, a020461, 10.1101/cshperspect.a020461 · DOI
  150. Menn, 2006, Origin of oligodendrocytes in the subventricular zone of the adult brain, J. Neurosci., 26, 7907, 10.1523/JNEUROSCI.1299-06.2006 · DOI · Paper page
  151. 2009, EGF induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes, Stem Cells, 27, 2032, 10.1002/stem.119 · DOI
  152. Aguirre, 2005, Overexpression of the epidermal growth factor receptor confers migratory properties to nonmigratory postnatal neural progenitors, J. Neurosci., 25, 11092, 10.1523/JNEUROSCI.2981-05.2005 · DOI
  153. Grinspan, 2002, Cells and signalling in oligodendrocyte development, J. Neuropath. Exp. Neurol., 61, 297, 10.1093/jnen/61.4.297 · DOI
  154. Bankston, 2013, Oligodendroglia and neurotrophic factors in neurodegeneration, Neurosci. Bull., 29, 216, 10.1007/s12264-013-1321-3 · DOI
  155. He, 2016, Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration, Brain Res., 1638, 209, 10.1016/j.brainres.2015.10.051 · DOI
  156. Temple, 1999, Stem cells in the adult mammalian central nervous system, Curr. Opin. Neurobiol., 9, 135, 10.1016/S0959-4388(99)80017-8 · DOI
  157. Akkermann, R., Jadasz, J.J., Azim, K., and Küry, P. (2016). Taking advantage of nature’s gift: Can endogenous neural stem cells improve myelin regeneration?. Int. J. Mol. Sci., 17. · DOI
  158. Raabe, 2004, Localization of neuregulin isoforms and erbB receptors in myelinating glial cells, Glia, 45, 197, 10.1002/glia.10311 · DOI
  159. Deadwyler, 2000, Neuregulins and erbB receptor expression in adult human oligodendrocytes, Glia, 32, 304, 10.1002/1098-1136(200012)32:3<304::AID-GLIA90>3.0.CO;2-Z · DOI
  160. Mayoral, 2016, The environment rules: Spatiotemporal regulation of oligodendrocyte differentiation, Curr. Opin. Neurobiol., 39, 47, 10.1016/j.conb.2016.04.002 · DOI
  161. Li, 2009, Two-tier transcriptional control of oligodendrocyte differentiation, Curr. Opin. Neurobiol., 19, 479, 10.1016/j.conb.2009.08.004 · DOI
  162. Moore, 2001, How factors secreted from astrocytes impact myelin repair, J. Neurosci. Res., 89, 13, 10.1002/jnr.22482 · DOI
  163. Kiray, 2016, The multifaceted role of astrocytes in regulating myelination, Exp. Neurol., 283, 541, 10.1016/j.expneurol.2016.03.009 · DOI
  164. Connor, 1995, Cellular management of iron in the brain, J. Neurol. Sci., 134, 33, 10.1016/0022-510X(95)00206-H · DOI
  165. Li, 2019, Astrocyte-to-astrocyte contact and a positive feedback loop of growth factor signaling regulate astrocyte maturation, Glia, 67, 1571, 10.1002/glia.23630 · DOI
  166. Hughes, 2021, Glial cells promote myelin formation and elimination, Front. Cell Dev. Biol., 9, 661486, 10.3389/fcell.2021.661486 · DOI
  167. Grove, 1996, Plasticity of astrocytes derived from aged mouse cerebral hemispheres: Changes with cell passage and immortalization, Brain Res. Bull., 39, 211, 10.1016/0361-9230(95)02130-2 · DOI
  168. Anlauf, 2013, Glutamine synthetase as an astrocytic marker: Its cell type and vescicle localization, Front. Endocrinol., 4, 144, 10.3389/fendo.2013.00144 · DOI
  169. Kettenmann, H., and Ranson, B.R. (2013). Amino Acid Neurotransmitter Synthesis and Removal. Neuroglia, Oxford University Press. [3rd ed.].
  170. Eng, 1990, Glutamine synthetase immunoreactivity is present in oligodendroglia of various regions of the central nervous system, Glia, 3, 335, 10.1002/glia.440030504 · DOI · Paper page
  171. Zhou, 2019, Selective deletion of glutamine synthetase in the mouse cerebral cortex induces glial dysfunction and vascular impairment that precede epilepsy and neurodegeneration, Neurochem. Int., 123, 22, 10.1016/j.neuint.2018.07.009 · DOI
  172. Zhou, 2020, Novel aspects of glutamine synthetase in ammonia homeostasis, Neurochem. Int., 140, 104809, 10.1016/j.neuint.2020.104809 · DOI
  173. Haim, 2021, Evidence for glutamine synthetase function in mouse spinal cord, Glia, 69, 2812, 10.1002/glia.24071 · DOI
  174. Gautier, 2015, Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors, Nat. Commun., 6, 8518, 10.1038/ncomms9518 · DOI
  175. Habermacher, 2019, Glutamate versus GABA in neuron-oligodendroglia communication, Glia, 67, 2092, 10.1002/glia.23618 · DOI
  176. Han, 1992, Mitogenic activity of epidermal growth factor on newborn rat astroglia: Interaction with insulin-like growth factors, Endocrinology, 131, 1134, 10.1210/endo.131.3.1380434 · DOI
  177. Chernausek, 1993, Insulin-like growth factor-I (IGF-I) production by astroglial cells: Regulation and importance for epidermal growth factor-induced cell replication, J. Neurosci. Res., 34, 189, 10.1002/jnr.490340206 · DOI
  178. Saneto, 1988, Insulin/insulin-like growth factor I and other epigenetic modulators of myelin basic protein expression in isolated oligodendrocyte progenitor cells, J. Neurosci. Res., 21, 210, 10.1002/jnr.490210213 · DOI
  179. Lazzarini, R.A. (2004). Oligodendrocyte lineage. Myelin Biology and Disorders, Elsevier-Academic Press.
  180. Hsieh, 2004, IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes, J. Cell. Biol., 164, 111, 10.1083/jcb.200308101 · DOI
  181. Ortiz, 2019, Neuronal activity in vivo enhances functional myelin repair, JCI Insight, 4, e123434, 10.1172/jci.insight.123434 · DOI
  182. Canoll, 1996, GGF/Neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors, Neuron, 17, 229, 10.1016/S0896-6273(00)80155-5 · DOI
  183. Roger, 1985, Antagonistic effect of thyrotropin and epidermal growth factor on thyroglobulin mRNA level in cultured thyroid cells, Eur. J. Biochem., 152, 239, 10.1111/j.1432-1033.1985.tb09189.x · DOI
  184. Johe, 1996, Single factors direct the differentiation of stem cells from the fetal and adult central nervous system, Genes Dev., 10, 3129, 10.1101/gad.10.24.3129 · DOI
  185. Nicolay, 2007, Transcriptional control of oligodendrogenesis, Glia, 55, 1287, 10.1002/glia.20540 · DOI
  186. Lee, 2016, Thyroid hormone signalling in oligodendrocytes: From extracellular transport to intracellular signal, Mol. Neurobiol., 53, 6568, 10.1007/s12035-016-0013-1 · DOI
  187. Vancamp, 2020, Thyroid hormone and neural stem cells: Repair potential following brain and spinal cord injury, Front. Neurosci., 14, 875, 10.3389/fnins.2020.00875 · DOI
  188. Pagnin, 2021, Role of thyroid hormones in normal and abnormal central nervous system myelination in humans and rodents, Front. Neuroendocrinol., 61, 100901, 10.1016/j.yfrne.2021.100901 · DOI
  189. Grade, 2013, Oligodendrogenesis from neural stem cells: Perspectives for remyelinating strategies, Int. J. Dev. Neurosci., 31, 692, 10.1016/j.ijdevneu.2013.01.004 · DOI
  190. Rivera, 2010, Deciphering the oligodendrocyte program of neural progenitors: Cell intrinsic and extrinsic regulators, Stem Cells Dev., 19, 595, 10.1089/scd.2009.0293 · DOI
  191. Long, K.L.P., Breton, J.M., Barraza, M.K., Perloff, O.S., and Kaufer, D. (2021). Hormonal regulation of oligodendrogenesis I: Effects across the lifespan. Biomolecules, 11. · DOI
  192. Breton, J.M., Long, K.L.P., Barraza, M.K., Perloff, O.S., and Kaufer, D. (2021). Hormonal regulation of oligodendrogenesis II: Implications for myelin repair. Biomolecules, 11. · DOI
  193. Webster, 1997, Growth factors and myelin regeneration in multiple sclerosis, Mult. Scler., 3, 113, 10.1177/135245859700300210 · DOI
  194. Franco, 2008, Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination, Exp. Neurol., 212, 458, 10.1016/j.expneurol.2008.04.039 · DOI
  195. Zhang, 2015, Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period, Exp. Biol. Med., 240, 1183, 10.1177/1535370214565975 · DOI
  196. Zhang, 2016, Thyroid hormone potentially benefits multiple sclerosis via facilitating remyelination, Mol. Neurobiol., 53, 4406, 10.1007/s12035-015-9375-z · DOI
  197. Gallo, 2014, Glial development: The crossroads of regeneration and repair in the CNS, Neuron, 83, 283, 10.1016/j.neuron.2014.06.010 · DOI
  198. Yao, 1995, Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis, Proc. Natl. Acad. Sci. USA, 92, 6190, 10.1073/pnas.92.13.6190 · DOI
  199. Liu, 1995, Insulin-like growth factor I treatment reduces clinical effects and lesion severity in acute experimental autoimmune encephalomyelitis, Mult. Scler. J., 1, 2, 10.1177/135245859500100102 · DOI
  200. Romano, R., and Bucci, C. (2020). Role of EGFR in the nervous system. Cells, 9. · DOI

200 of 460 shown

Cited by

Sorted by citations

Metadata

Authors
Scalabrino, G.
Venue
Biomedicines
Publisher
MDPI AG
Published
2022-03-30
Volume
10
Issue
4
Pages
815
ISSN
2227-9059
DOI
10.3390/biomedicines10040815
PMC
PMC9026986
Cited by
10
References
27
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review